Sfoglia per Autore
Epsilon: A prognostic score for immunotherapy in advanced non-small-cell lung cancer: A validation cohort
2019-01-01 Prelaj, A.; Ferrara, R.; Rebuzzi, S. E.; Proto, C.; Signorelli, D.; Galli, G.; De Toma, A.; Randon, G.; Pagani, F.; Viscardi, G.; Brambilla, M.; Trevisan, B.; Ganzinelli, M.; Martinetti, A.; Gallucci, R.; Di Mauro, R. M.; Molino, G.; Zilembo, N.; Torri, V.; de Braud, F. M.; Garassino, M. C.; Lo Russo, G.
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer
2019-01-01 Galli, G.; De Toma, A.; Pagani, F.; Randon, G.; Trevisan, B.; Prelaj, A.; Ferrara, R.; Proto, C.; Signorelli, D.; Ganzinelli, M.; Zilembo, N.; de Braud, F.; Garassino, M. C.; Lo Russo, G.
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy
2019-01-01 Galli, G.; Proto, C.; Signorelli, D.; Imbimbo, M.; Ferrara, R.; Prelaj, A.; De Toma, A.; Ganzinelli, M.; Zilembo, N.; De Braud, F.; Garassino, M. C.; Lo Russo, G.
Is there an interplay between immune checkpoint inhibitors, thromboprophylactic treatments and thromboembolic events? Mechanisms and impact in non-small cell lung cancer patients
2019-01-01 Nichetti, F.; Ligorio, F.; Zattarin, E.; Signorelli, D.; Prelaj, A.; Proto, C.; Galli, G.; Marra, A.; Apollonio, G.; Porcu, L.; de Braud, F.; Lo Russo, G.; Ferrara, R.; Garassino, M. C.
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
2019-01-01 Proto, C.; Ferrara, R.; Signorelli, D.; Lo Russo, G.; Galli, G.; Imbimbo, M.; Prelaj, A.; Zilembo, N.; Ganzinelli, M.; Pallavicini, L. M.; De Simone, I.; Colombo, M. P.; Sica, A.; Torri, V.; Garassino, M. C.
The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma
2019-01-01 Proto, C.; Signorelli, D.; Mallone, S.; Prelaj, A.; Lo Russo, G.; Imbimbo, M.; Galli, G.; Ferrara, R.; Ganzinelli, M.; Leuzzi, G.; Greco, F. G.; Calareso, G.; Botta, L.; Gatta, G.; Garassino, M.; Trama, A.
Gastrointestinal stromal tumors and second primary malignancies: a retrospective monocentric analysis
2020-01-01 Comandini, D; Grassi, M; Prelaj, A; Martelli, V; Damiani, A; Damiano, G; Rebuzzi, S Elena
Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system
2020-01-01 Prelaj, A; Proto, C; Lo Russo, G; Signorelli, D; Ferrara, R; Mensah, M; Galli, G; De Toma, A; Viscardi, G; Brambilla, M; Lobefaro, R; Trevisan, B; Trovo, F; Torri, V; Sozzi, G; Garassino, Mc; Boeri, M
ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?
2020-01-01 Nichetti, F.; Russo, G. L.; Prelaj, A.; Provenzano, L.; de Braud, F.; Cabiddu, M.; Garassino, M. C.; Petrelli, F.
DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non–Small-Cell Lung Cancer: An External Validation
2020-01-01 Prelaj, A.; Lo Russo, G.; Proto, C.; Signorelli, D.; Ferrara, R.; Galli, G.; De Toma, A.; Randon, G.; Pagani, F.; Trevisan, B.; Ganzinelli, M.; Zilembo, N.; Montrone, M.; Longo, V.; Pesola, F.; Pizzutilo, P.; Del Bene, G.; Varesano, N.; Galetta, D.; Torri, V.; Garassino, M. C.; Di Maio, M.; Catino, A.
Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study
2020-01-01 Trama, A.; Proto, C.; Signorelli, D.; Garassino, M. C.; Lo Russo, G.; Ganzinelli, M.; Prelaj, A.; Mensi, C.; Gangemi, M.; Gennaro, V.; Chellini, E.; Caldarella, A.; Angelillo, I. F.; Ascoli, V.; Pascucci, C.; Tagliabue, G.; Cusimano, R.; Bella, F.; Falcini, F.; Merler, E.; Masanotti, G.; Ziino, A.; Michiara, M.; Gola, G.; Storchi, C.; Mangone, L.; Vitale, M. F.; Cirilli, C.; Tumino, R.; Scuderi, T.; Fanetti, A. C.; Piffer, S.; Tiseo, M.; Gatta, G.; Botta, L.
SMO mutations confer poor prognosis in malignant pleural mesothelioma
2020-01-01 Signorelli, D.; Proto, C.; Botta, L.; Trama, A.; Tiseo, M.; Pasello, G.; Russo, G. L.; Fabbri, A.; Imbimbo, M.; Busico, A.; Prelaj, A.; Ferrara, R.; Galli, G.; de Toma, A.; Tamborini, E.; Pastorino, U.; de Braud, F.; Gatta, G.; Garassino, M. C.; Ganzinelli, M.
Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled Analysis
2020-01-01 Babacan, N. A.; Pina, I. B.; Signorelli, D.; Prelaj, A.; Garassino, M. C.; Tanvetyanon, T.
EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non–Small-cell Lung Cancer Treated With Immunotherapy
2020-01-01 Prelaj, A.; Rebuzzi, S. E.; Pizzutilo, P.; Bilancia, M.; Montrone, M.; Pesola, F.; Longo, V.; Del Bene, G.; Lapadula, V.; Cassano, F.; Petrillo, P.; Bafunno, D.; Varesano, N.; Lamorgese, V.; Mastrandrea, A.; Ricci, D.; Catino, A.; Galetta, D.
Immunotherapy beyond progression in patients with advanced non-small cell lung cancer
2020-01-01 Ge, X.; Zhang, Z.; Zhang, S.; Yuan, F.; Zhang, F.; Yan, X.; Han, X.; Ma, J.; Wang, L.; Tao, H.; Li, X.; Zhi, X.; Huang, Z.; Hofman, P.; Prelaj, A.; Banna, G. L.; Mutti, L.; Hu, Y.; Wang, J.
Novel emerging molecular targets in non-small cell lung cancer
2021-01-01 Rebuzzi, S. E.; Zullo, L.; Rossi, G.; Grassi, M.; Murianni, V.; Tagliamento, M.; Prelaj, A.; Coco, S.; Longo, L.; Bello, M. G. D.; Alama, A.; Dellepiane, C.; Bennicelli, E.; Malapelle, U.; Genova, C.
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors
2021-01-01 Occhipinti, Mario; Brambilla, Marta; Galli, Giulia; Manglaviti, Sara; Giammaruco, Maristella; Prelaj, Arsela; Ferrara, Roberto; De Toma, Alessandro; Proto, Claudia; Beninato, Teresa; Zattarin, Emma; Lo Russo, Giuseppe; Gelibter, Alain Jonathan; Simmaco, Maurizio; Preissner, Robert; Garassino, Marina Chiara; De Braud, Filippo; Marchetti, Paolo
Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis
2021-01-01 Liu, Y.; Yang, S.; Zhao, J.; He, Z.; Ma, J.; Guo, Y.; Wang, W.; Yoshizawa, A.; Prelaj, A.; Tiseo, M.; Normanno, N.; Van Schil, P. E.; Wang, Q.; Yang, X.
Abstract PO-065: Artificial intelligence to improve selection for NSCLC patients treated with immunotherapy
2021-01-01 Prelaj, Arsela; Boeri, Mattia; Robuschi, Alessandro; Proto, Claudia; Russo, Giuseppe Lo; Ferrara, Roberto; Galli, Giulia; De Toma, Alessandro; Brambilla, Marta; Occhipinti, Mario; Manglaviti, Sara; Labianca, Alice; Beninato, Teresa; Bini, Marta; Mensah, Mavis; Ganzinelli, Monica; Zilembo, Nicoletta; de Braud, Filippo; Sozzi, Gabriella; Restelli, Marcello; Pedrocchi, Alessandra; Garassino, Marina Chiara; Trovo, Francesco
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers
2021-01-01 Lobefaro, R.; Viscardi, G.; Di Liello, R.; Massa, G.; Iacovino, M. L.; Sparano, F.; Della Corte, C. M.; Ferrara, R.; Signorelli, D.; Proto, C.; Prelaj, A.; Galli, G.; De Toma, A.; Brambilla, M.; Ganzinelli, M.; Trevisan, B.; Ciardiello, F.; De Braud, F.; Morgillo, F.; Garassino, M. C.; Lo Russo, G.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile